Company Filing History:
Years Active: 2023
Title: Junqing Li - Innovator in Kinase Inhibitor Research
Introduction
Junqing Li is a prominent inventor based in Fujian, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. His innovative work has led to the creation of valuable compounds that have potential therapeutic applications.
Latest Patents
Junqing Li holds a patent for "Heteroaryl compounds as kinase inhibitor." This patent describes compounds of formula (I) that exhibit activity on a receptor protein tyrosine kinase. The patent also includes details about various substituents such as R, A, Q, Z, X, and W, along with their solvates, hydrates, tautomers, or pharmaceutically acceptable salts.
Career Highlights
Li is associated with Fujian Haixi Pharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key player in the innovation of new therapeutic agents.
Collaborations
Some of his notable coworkers include Yan Feng and Ruyong Wang, who contribute to the collaborative efforts in research and development at Fujian Haixi Pharmaceuticals Co., Ltd.
Conclusion
Junqing Li's contributions to the field of kinase inhibitors exemplify the importance of innovation in pharmaceuticals. His work not only enhances our understanding of receptor protein tyrosine kinases but also paves the way for future therapeutic advancements.